ARCHIVES

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

Review Panel: NCI Intramural Program Is Too Large, Redundant, Hierarchical

May 19, 1995

NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.

May 4, 2001

CCOP Applications Total 162; Three Committees, Headed By Ahmann, Loeb, Spur Will Review Them

November 19, 1982

NCI-Approved Clinical Trials

May 26, 2006

Cancer Advocacy: Jay Hedlund Resigns As NPCC President

May 14, 1999

Additional DCE Contract Concepts

November 16, 1984